Clinical Trial Update: Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating metformin in combination with cisplatin and radiation for head and neck squamous cell carcinoma has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• metformin (metformin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-07-21